Literature DB >> 20488521

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action.

Ben J Marais1, Mario C Raviglione, Peter R Donald, Anthony D Harries, Afranio L Kritski, Stephen M Graham, Wafaa M El-Sadr, Mark Harrington, Gavin Churchyard, Peter Mwaba, Ian Sanne, Stefan H E Kaufmann, Christopher J M Whitty, Rifat Atun, Alimuddin Zumla.   

Abstract

The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20488521     DOI: 10.1016/S0140-6736(10)60554-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

1.  Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs.

Authors:  Alimuddin Zumla; Rifat Atun; Markus Maeurer; Peter S Kim; Patrick Jean-Philippe; Richard Hafner; Marco Schito
Journal:  J Infect Dis       Date:  2012-03-22       Impact factor: 5.226

2.  Non-invasive diagnosis of lung tuberculosis in children by single voxel ¹H-magnetic resonance spectroscopy.

Authors:  Ky Santy; Phang Nan; Yay Chantana; Denis Laurent; Ianina Scheer; Beat Steinmann; David Nadal; Beat Richner
Journal:  Eur J Pediatr       Date:  2012-07-07       Impact factor: 3.183

3.  Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Authors:  Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

4.  Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting.

Authors:  Lesley Scott; Anura David; Lyndel Govender; Jan Furrer; Modiehi Rakgokong; Ziyaad Waja; Neil Martinson; Gabriel Eisenberg; Elizabeth Marlowe; Wendy Stevens
Journal:  J Mol Diagn       Date:  2020-08-01       Impact factor: 5.568

5.  Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis.

Authors:  Rongjun He; Zhi-Hong Yu; Ruo-Yu Zhang; Li Wu; Andrea M Gunawan; Zhong-Yin Zhang
Journal:  ACS Med Chem Lett       Date:  2015-11-03       Impact factor: 4.345

Review 6.  Priorities for tuberculosis research: a systematic review.

Authors:  Jamie Rylance; Madhukar Pai; Christian Lienhardt; Paul Garner
Journal:  Lancet Infect Dis       Date:  2010-11-01       Impact factor: 25.071

7.  Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.

Authors:  Viviane D Lima; Reuben Granich; Peter Phillips; Brian Williams; Julio S G Montaner
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

8.  Setting priorities for a research agenda to combat drug-resistant tuberculosis in children.

Authors:  B Velayutham; D Nair; S Ramalingam; C M Perez-Velez; M C Becerra; S Swaminathan
Journal:  Public Health Action       Date:  2015-12-21

9.  Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.

Authors:  P Macpherson; M Dimairo; T Bandason; A Zezai; S S Munyati; A E Butterworth; S Mungofa; S Rusakaniko; K Fielding; P R Mason; E L Corbett
Journal:  Int J Tuberc Lung Dis       Date:  2011-10       Impact factor: 2.373

10.  Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study.

Authors:  Emily B Wong; Stephen Olivier; Resign Gunda; Olivier Koole; Ashmika Surujdeen; Dickman Gareta; Day Munatsi; Tshwaraganang H Modise; Jaco Dreyer; Siyabonga Nxumalo; Theresa K Smit; Greg Ording-Jespersen; Innocentia B Mpofana; Khadija Khan; Zizile E L Sikhosana; Sashen Moodley; Yen-Ju Shen; Thandeka Khoza; Ngcebo Mhlongo; Sanah Bucibo; Kennedy Nyamande; Kathy J Baisley; Diego Cuadros; Frank Tanser; Alison D Grant; Kobus Herbst; Janet Seeley; Willem A Hanekom; Thumbi Ndung'u; Mark J Siedner; Deenan Pillay
Journal:  Lancet Glob Health       Date:  2021-07       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.